Medical Editorial Standards

Effective August 6, 2026

Purpose and scope

These standards apply to Identity Aesthetics patient-education pages about aesthetic medicine, skin treatments, medical wellness, weight management, hormone optimization and peptide therapy. The content supports—not replaces—an individualized medical evaluation, diagnosis or treatment plan.

Who prepares our content

Patient education is prepared by the Identity Aesthetics Clinical Editorial Team. The team organizes clinical concepts into clear, consumer-facing language, identifies primary sources and separates established evidence from emerging, off-label, compounded or investigational uses.

Medical review and clinical oversight

Clinical content is medically reviewed by Dallas Alvey, MD, DDS, Chief Medical Officer, and Ike Nwanonyiri, MD, Chief Medical Officer, with psychosocial review by Clotie Wayland, LCSW. Medical review evaluates accuracy, balance, risk language, regulatory distinctions and whether the page appropriately directs readers toward professional evaluation. Psychosocial review considers clarity, stigma-aware language, emotional well-being and relevant behavioral context. A medical-review date appears on applicable pages.

Source hierarchy

We prioritize authoritative primary sources. Depending on the subject, these may include:

• FDA prescribing information, safety communications, databases and enforcement notices.
• CDC, HHS, NIH, DailyMed, ClinicalTrials.gov and other government health resources.
• Original peer-reviewed clinical studies and evidence-based professional guidance.
• Manufacturer documentation for device specifications and authorized treatment capabilities, clearly distinguished from independent clinical evidence.

How regulatory status is described

“FDA approved” refers only to a specific product for a specific labeled indication. Off-label clinical use, compounded medication, investigational therapy and products labeled for research use only are identified separately. Compounded drugs are not FDA approved, and investigational or research-only products are not presented as established patient treatments.

Balance, benefits and limitations

Pages are designed to explain potential benefits alongside candidacy, contraindications, downtime, material risks, evidence limitations and reasonable alternatives. Results vary, no outcome is guaranteed and marketing language does not override medical evidence or professional judgment.

Updates and corrections

Clinical pages are reviewed when meaningful safety, labeling, approval, evidence or service changes occur. High-change subjects may be reviewed more frequently. The evidence-review date reflects the most recent clinical review; the page-modified date may also reflect design, accessibility or navigation updates. If a material error is identified, we correct it promptly and reassess connected pages.

Local and telehealth information

In-office availability, telehealth eligibility and treatment access depend on the service, patient location, provider licensure, medical appropriateness and applicable law. Telehealth information is not a promise that a treatment can be prescribed or performed remotely.

Questions or corrections

To ask about a source, request clarification or report a possible error, email info@713botoxme.com or call 713-268-6963.